Compounds > 5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one
Page last updated: 2024-09-03

5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one and guanosine triphosphate

5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one has been researched along with guanosine triphosphate in 1 studies

Compound Research Comparison

Studies
(5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one)		Trials
(5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one)		Recent Studies (post-2010)
(5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one)		Studies
(guanosine triphosphate)		Trials
(guanosine triphosphate)		Recent Studies (post-2010) (guanosine triphosphate)
110114,728252,115

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carrigan, KJ; Evans, DL; Figur, LM; Hsi, RS; Lahti, RA; Moon, MW1

Other Studies

1 other study(ies) available for 5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one and guanosine triphosphate

ArticleYear
Dopamine D2 receptor binding properties of [3H]U-86170, a dopamine receptor agonist.
    European journal of pharmacology, 1991, Sep-17, Volume: 202, Issue:2

    Topics: Aminoquinolines; Animals; CHO Cells; Cloning, Molecular; Corpus Striatum; Cricetinae; Dopamine Agents; Dopamine Antagonists; GTP-Binding Proteins; Guanosine Triphosphate; Rats; Receptors, Dopamine; Receptors, Dopamine D2

1991